Category: News

All Day Webinar: The Spectrum of Celiac Disease and Response to the Gluten-Free Diet

March 11, 2023 11am-5pm

Register here

The University of Chicago Celiac Disease Research Center is presenting this webinar.

The following information is from their website:

Convening experts from around the country, this activity will offer insight into a variety of experiences and research as well as provide highlights of the most current information by experts relating to celiac disease and the response to the gluten-free diet. It will focus on diagnosis, gluten challenge, and healing. It will provide information about the latest research and clinical approaches, and it will educate participants about the future of this disease so they can provide better care to their patients.

Target Audience

This activity is designed for physicians, nurses, pharmacists, dietitians, researchers, other healthcare professionals, and patients dedicated to improving the diagnosis and treatment of celiac disease.

Learning Objectives

After this activity, participants will be able to:

  • Discuss an evidence-based approach to diagnosing and managing the spectrum of celiac disease;
  • Recall how to use the gluten-free diet centering diagnosis, gluten challenge, and healing;
  • Identify diagnosis and healing complexities associated with celiac disease;
  • Describe treatment plans that cover the spectrum of celiac disease and the patient’s response to the gluten-free diet;
  • Name new advances in diagnosis, healing, and perspectives on the gluten challenge in celiac disease;
  • Analyze why a gluten-free diet is a critical component of celiac disease treatment.

Webinar: Living Well with Celiac Disease and Diabetes Mellitus

Feb 15, 1pm

Register here

From the registration website:

“Living Well with Celiac Disease and Diabetes Mellitus”

Join the Harvard Medical School Celiac Research Program and the National Celiac Association for the first webinar in our Spring 2023 “Ask the Experts” series. Speakers will present on selected topics for 60 minutes, followed by 15 minutes for Q&A, on Wednesday, February 15, 2023, from 1- 2:15 pm ET.

Together Caitlin Colling, MD, adult endocrinologist at MassGeneral for Children (MGfC), and Janaki Vakharia, MD, senior combined adult and pediatric endocrinology fellow at MGH and MGfC, will cover the importance of screening and diagnosis of Type 1 diabetes in the celiac population and the medical care of diabetes in pediatrics, young adults, and adults. Registered Dietitian Sharon Weston, MS, RD, CPS, LDN, from the Celiac Disease Program at Boston Children’s Hospital, will address nutritional concerns and challenges of adhering to the gluten-free diet while managing diabetes effectively.

Lee Graham, executive director of the National Celiac Association, will introduce the webinar, which will be moderated by Ciarán P. Kelly, MD, medical director of the Celiac Center at Beth Israel Deaconess Medical Center. A Q&A session will follow the presentations; please submit general questions below or during the webinar on the Zoom platform.

Continuing Education Units (CEUs): This course (220323-RSS) is approved by the Boston Children’s Hospital’s Continuing Education Department for 1.25 AMA PRA Category 1 Credits ™ for physicians, 1.25 contact hours for nurses, 1.25 ACE CE continuing education credits for social workers, and 1.25 CEUs for Registered Dietitians. Instructions for claiming credits will be made available during the webinar and transcripts will be available within 30 days.

Register here

Updated guidance for celiac disease diagnosis, management in children, adults

The American Journal of Gastroenterology published an update to the 2013 American College of Gastroenterology Guideline on the Diagnosis and Management of Celiac Disease with updated recommendations for the evaluation and management of patients with celiac disease (CD). 

An expert panel created updated recommendations, which include the following:

  1. EGD with multiple biopsies of the duodenum are necessary for CD diagnosis in adults and children.
  2. A combination of TTG-IgA >10X normal and + EMA on a second sample for diagnosis of CD in children.
  3. The goal of intestinal healing as the endpoint of treatment.
  4. Suggest against the routine use of gluten detection devices among patients with CD.
  5. Insufficient evidence to recommend for or against the use of probiotics.
  6. Although consumption of oats seems safe for most patients with CD, a subset of patients may be immunogenic.
  7. Vaccinate to prevent pneumococcal disease.
  8. Recommend for case finding of CD and against mass screening.
  9. Anti-TTGA-IgA is the preferred single test for children < 2 years that are not IgA deficient.

The publication, with additional recommendations, can be read here.

Rubio-Tapia, Alberto MD1; Hill, Ivor D. MD2; Semrad, Carol MD3; Kelly, Ciarán P. MD4; Lebwohl, Benjamin MD, MS5. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. The American Journal of Gastroenterology 118(1):p 59-76, January 2023. | DOI: 10.14309/ajg.0000000000002075

Celiac Connect: Management of the poorly responsive patient. Can the diet be stricter? Is this refractory celiac disease?

The Celiac Disease Center at Columbia University is presenting this program on February 3, 10 am – 12 pm.

Register here

10:00 AM – 10:30 AM Assessment of the Poorly Responsive Patient

10:30 AM – 11:00 AM Refractory Celiac Disease: Diagnosis and Management

11:00 AM – 11:30 AM Dietary Management of Poorly Responsive Patients

11:30 AM – 12:00 PM Case Presentation/Q&A

The target audience is adult and pediatric physicians and physician’s assistants, nurse practitioners, fellows, dietitians and nutritionists, researchers and patients.

Register here